Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms

Dig Liver Dis. 2004 Jun;36(6):423-5. doi: 10.1016/j.dld.2003.10.021.

Abstract

Infliximab has been proven to be an effective therapy in a miscellany of rheumatic diseases and has been approved for the treatment of moderate-to-severe Crohn's disease with an inadequate response to conventional therapy and for the management of enterocutaneous fistulas. Data about the role of infliximab in ulcerative colitis are still controversial. Here, we report a case of a patient with sacroileitis and peripheral arthropathy associated with left-sided ulcerative colitis who achieved a sustained clinical remission after infliximab therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Colitis, Ulcerative / complications*
  • Colitis, Ulcerative / drug therapy*
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Sacroiliac Joint*
  • Synovitis / drug therapy*
  • Synovitis / etiology

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab